Vivek Ramaswamy

Vivek Ramaswamy discloses dealings in 2 companies, chiefly Roivant Sciences Ltd. and Strive, Inc. We count 36 filings; the first trade dates from 22 February 2023 and the latest from 15 December 2025.

Market trades split into 1 purchase (€1.1M) and 17 sales (€197.4M). Netting one side against the other leaves €196.4M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant and 8 option exercises. In 2025 alone, the filings show 1 purchase and 15 sales.

On 15 December 2025 came the latest disclosure, an open-market sale for €14.3M in Roivant Sciences Ltd. The clock since the last published purchase (7 November 2025) now reads 351 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.